GL1X · GenesisL1 explorer

MolNFT v1 · #69938 · protein

Structure of bace bound to SCH736062

3L5E · Beta-secretase 1: “Structure of bace bound to SCH736062”. X-ray diffraction, 1 ligand (BDW), 7 pockets (best druggability 0.67). MolNFT v1 #69938 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
3L5E
Type
protein
Length
776 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Beta-secretase 1
EC
3.4.23.46
UniProt
P56817
Ligands
BDW
Pockets
7 · best druggability 0.67

Structure

x-ray diffraction · 2 distinct chains · 16% helix, 39% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABeta-secretase 1 (EC 3.4.23.46)protein39016% helix, 39% strandP56817
BBeta-secretase 1 (EC 3.4.23.46)protein38616% helix, 39% strandP56817

Ligands and binding sites

  • BDW · (4S)-1-(4-{[(2Z,4R)-4-(2-cyclohexylethyl)-4-(cyclohexylmethyl)-2-imino-5-oxoimidazolidin-1-yl]methyl}benzyl)-4-propylimidazolidin-2-one · ligand · 2 copies · chains A, B
  • TAR · D(-)-tartaric acid · additive · 3 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15350.670.7742BDW
2740.590.8926empty
33610.580.7638BDW
4840.560.8626empty
51330.450.7721empty

Interfaces

1 interface between chains.

  • A–B · 312 Ų buried · 6 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 6 disulfide (disulfide).

Compared structures

  • 3L5E · Structure of BACE Bound to SCH736062 · the same entry in another collection · chain A against A, TM-score 1.00
  • P56817 · AlphaFold monomer V2.0 prediction for beta-secretase 1 (P56817) · a predicted model of the same protein · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.